Prospecto: information for the user
Salmeterol/FluticasonaCipla25 micrograms/125 micrograms/inhalation, suspension for inhalation in a pressurized container
salmeterol/fluticasone propionate
Read this prospectus carefully before starting to use this medication, as it contains important information for you.
-Keep this prospectus, as you may need to refer to it again.
-If you have any questions, consult your doctor or pharmacist.
-This medication has been prescribed only for you, and you should not give it to others who may have the same symptoms as you, as it may harm them.
-If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this prospectus. See section 4.
1.What is Salmeterol/Fluticasona Cipla and what is it used for
2.What you need to know before starting to use Salmeterol/Fluticasona Cipla
3.How to use Salmeterol/Fluticasona Cipla
4.Possible adverse effects
5.Storage of Salmeterol/Fluticasona Cipla
6.Contents of the container and additional information
Salmeterol/Fluticasona Cipla contains two active ingredients, salmeterol and fluticasone propionate:
Your doctor has prescribed this medication to help prevent respiratory problems such as asthma.
You must use Salmeterol/Fluticasona Cipla every day as recommended by your doctor. This will ensure the medication works correctly in controlling your asthma.
Salmeterol/Fluticasona Ciplahelps prevent shortness of breath and wheezing. However, Salmeterol/Fluticasona Cipla should not be used to relieve a sudden attack of shortness of breath or wheezing. In such a case, you must use your quick-relief medication, such as salbutamol. You should carry your quick-relief medication with you at all times.
No use Salmeterol/FluticasonaCipla
If you are allergic (hypersensitive) to salmeterol, fluticasone propionate or to any of the other ingredients, norflurane (HFC-134a).
Warnings and precautions
Your doctor will monitor your treatment more closely if you have any of the following conditions:
If you have had any of these conditions, inform your doctor before using Salmeterol/Fluticasona Cipla.
Contact your doctor if you experience blurred vision or other visual disturbances.
Use of Salmeterol/FluticasonaCiplawith other medications
Inform your doctor or pharmacist if you are taking or have recently taken other medications, including those purchased without a prescription. This is because, in some cases, Salmeterol/Fluticasona Cipla should not be administered with other medications.
Inform your doctor if you take the following medications, before starting to use Salmeterol/Fluticasona Cipla:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Salmeterol/Fluticasona Cipla is unlikely to affect your ability to drive or operate machinery.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your symptoms may be well controlled using Salmeterol/Fluticasona Cipla twice a day. If so, your doctor may decide to reduce your dose to once a day. The dose may change to:
It is very important that you follow your doctor's instructions on how many applications and how often you should administer them.
If you are using Salmeterol/Fluticasona Cipla to treat asthma, your doctor will want to monitor your symptoms regularly.
If your asthma worsens or you have greater difficulty breathing, see your doctor immediately. You may notice more wheezing or a feeling of choking more often or that you have to use your rescue medication more frequently. If any of these things happen, you should continue using Salmeterol/Fluticasona Cipla, but do not increase the number of applications. Your respiratory disease may worsen and seriously harm you. See your doctor, as you may need additional treatment.
Instructions for use
Each time you activate the inhaler, one application will be released and the counter will decrease by one unit.
Checking the inhaler
1. If you are using the inhaler for the first time, check that it works properly. Remove the mouthpiece protector by pressing it gently on both sides with your thumb and index finger and pulling it off.
2. To make sure it works, shake the inhaler well, direct the mouthpiece away from you, and press the cartridge down to release one application into the air. Repeat these steps, shaking the inhaler before releasing each application, until the counter marks 120. If you have not used your inhaler for a week or more, release two applications of the medication into the air.
Using the inhaler
It is essential to start breathing as slowly as possible just before using your inhaler.
1. It is recommended that you stand or sit upright while using the inhaler.
2. Remove the mouthpiece protector (as shown in the figure). Check inside and out that the mouthpiece is clean and free of any foreign particles (figure A).
3. Shake the inhaler 4 or 5 times to ensure the removal of any foreign particles and that the inhaler's contents are well mixed (figure B).
4. Hold the inhaler in a vertical position with your thumb on the base of the inhaler, below the mouthpiece. Exhale as much air as possible (figure C).
5. Place the mouthpiece in your mouth, between your teeth. Close your lips around the mouthpiece. Do not bite it (figure D).
6. Take a deep breath in through your mouth slowly and deeply. Immediately after starting to breathe in, press firmly on the top of the inhaler to release the medication. Do this while continuing to breathe in deeply and constantly (figure D).
7. Hold your breath, remove the inhaler from your mouth by releasing your thumb from the top of the inhaler. Continue holding your breath for a few seconds, as long as possible (figure D).
8. Wait approximately half a minute between each medication application and then repeat steps 3 to 7.
9. After using it, rinse your mouth with water and spit it out and/or brush your teeth. This will help prevent mouth ulcers and sore throat.
10. After using it, always put the mouthpiece protector back on immediately, to preserve it from dust. When the mouthpiece protector is put back on correctly, it will make a "click" sound. If it does not make a "click" sound, turn the mouthpiece protector around, put it back on, and try again. Do not use excessive force.
Take your time in steps 4, 5, 6, and 7. It is essential to breathe out as slowly as possible just before using the inhaler. The first time you use the inhaler, you should use it in front of a mirror. If you see "mist" coming out of the top of the inhaler or from the sides of your mouth, you should start again from step 3.
If you or your child find it difficult to use the inhaler, your doctor, nurse, or other healthcare professional may recommend using the inhaler with a spacer device, such as Volumatic or AeroChamber Plus. Your doctor, nurse, pharmacist, or other healthcare professional should show you how to use the spacer device with your inhaler, how to maintain your spacer device, and answer any questions you may have. If you are using the spacer device with your inhaler, it is essential that you do not stop using it without consulting your doctor or nurse first. Also, it is essential that you do not change the type of spacer device you are using without consulting your doctor. If you stop using the spacer device or change the type of spacer device, your doctor may need to change the dose of medication needed to control your asthma. Always consult your doctor before making any changes to your asthma treatment.
Some people with limited hand strength may find it easier to hold the inhaler with both hands. Place both index fingers on the top of the inhaler and both thumbs on the base, below the mouthpiece.
You should get a replacement inhaler when the indicator marks 40 and changes from green to red. Stop using the inhaler when the indicator marks 0, as the remaining applications in the cartridge may not be enough to complete a dose. Never try to modify the indicator or remove the indicator from the metal cartridge.
Cleaning the inhaler
To prevent your inhaler from blocking, it is essential to clean it at least once a week.
To clean your inhaler:
Do not submerge the metal cartridge in water.
If you use more Salmeterol/Fluticasona Cipla than you should
It is very important to use the inhaler as instructed. If you accidentally take a higher dose than recommended, consult your doctor or pharmacist. You may notice that your heart beats faster than normal and feel tremors. You may also have headaches, dizziness, muscle weakness, and joint pain.
If you have used high doses for a long time, you should ask your doctor or pharmacist for advice. This is because high concentrations of Salmeterol/Fluticasona Cipla can reduce the amount of steroid hormones produced by the adrenal gland.
In case of overdose, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount administered.
If you forget to use Salmeterol/Fluticasona Cipla
Do not take a double dose to compensate for the missed doses. Take the next dose at the usual time.
If you interrupt treatment with Salmeterol/Fluticasona Cipla
It is very important to use Salmeterol/Fluticasona Cipla every day as instructed.Continue taking it until your doctor tells you to stop. Do not stop using Salmeterol/Fluticasona Cipla abruptly.This may worsen your breathing.
Additionally, if you stop taking Salmeterol/Fluticasona Cipla suddenly or reduce your dose, you may (very rarely) cause problems with your adrenal gland (adrenal insufficiency), which sometimes causes adverse effects.
These adverse effects may include any of the following:
When your body is under stress, such as fever, trauma (e.g., car accident), infection, or surgery, adrenal insufficiency may worsen and you may experience any of the adverse effects listed above.
If you experience any adverse effects, consult your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe an additional dose of corticosteroids in tablets during that time (such as prednisolone).
If you have any other questions about using this medication, ask your doctor, nurse, or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. To reduce the occurrence of side effects, your doctor will prescribe the lowest dose of Salmeterol/Fluticasona Cipla that controls your asthma.
Allergic reactions: you may notice that your breathing suddenly worsens immediately after using Salmeterol/Fluticasona Cipla.Cipla.You may experience wheezing and coughing or shortness of breath. You may also notice itching, hives (urticaria), and swelling (usually of the face, lips, tongue, or throat). You may also feel, suddenly, that your heart is beating very fast, feel like you are losing consciousness, and dizziness (which can lead to collapse or loss of consciousness).If you experience any of these side effects or if they appear suddenly after using Salmeterol/Fluticasona CiplaCipla, stop taking Salmeterol/Fluticasona CiplaCiplaand inform your doctor immediately.Allergic reactions to Salmeterol/Fluticasona Cipla are rare (affect less than 1 in 100 people).
The following are other side effects:
Very common (may affect more than 1 in 10 people)
-Headache, usually improves with continued treatment.
-An increase in the number of colds in patients with COPD has been reported.
Common (may affect less than 1 in 10 people)
-Mouth ulcers (itching, appearance of yellowish cream-colored ulcers) in the mouth and throat. Also, tongue pain, hoarseness, and throat irritation. Rinsing the mouth with water and spitting it out and/or brushing your teeth immediately after each dose of medication may help. Your doctor may prescribe antifungal medication for the treatment of mouth ulcers.
-Joint pain, inflammation, and muscle pain.
-Muscle cramps.
The following side effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
-Pneumonia and bronchitis (pulmonary infection). Inform your doctor if you notice any of the following symptoms: increased sputum production, change in sputum color, fever, chills, increased cough, increased respiratory difficulty.
-Cardiac arrhythmias and fractures.
-Swelling of the sinuses (sensation of tension or congestion in the nose, cheeks, and behind the eyes, sometimes with a pulsating pain).
-Reduction of potassium levels in the blood (may feel irregular heartbeats, muscle weakness, cramps).
Rare (may affect less than 1 in 100 people)
-Increased blood sugar levels (hyperglycemia). If you have diabetes, you will need to monitor your blood sugar levels more frequently and adjust your usual diabetes treatment as needed.
-Cataracts (opacity of the lens of the eye).
-Very fast heart rate (tachycardia).
-Feeling tremors and a fast or irregular heart rate (palpitations). These side effects are usually harmless and decrease when treatment continues.
-Chest pain.
-Feeling anxious (occurs mainly in children).
-Sleep disturbances.
-Skin rash.
-Allergic skin eruption.
Uncommon (may affect less than 1 in 1,000 people)
-Respiratory difficulties or wheezing that worsen immediately after using Salmeterol/Fluticasona Cipla. If this happens, stop using Salmeterol/Fluticasona Cipla. Use your quick-relief inhaler to improve your breathing and inform your doctor immediately.
-Salmeterol/Fluticasona Cipla may increase normal hormone production, particularly if you have been taking high doses for long periods of time. The effects include:
-Delayed growth in children and adolescents.
-Decreased bone mineral density.
-Glaucoma.
-Weight gain.
-Rounded face (moon-shaped) (Cushing's syndrome).
-Your doctor will regularly monitor any of these side effects and ensure that you are taking the lowest dose of Salmeterol/Fluticasona Cipla to control your asthma.
-Changes in behavior, such as hyperactivity and irritability (these effects occur mainly in children).
-Irregular heartbeats or extra heartbeats (arrhythmias). Consult your doctor, but do not stop taking Salmeterol/Fluticasona Cipla unless your doctor tells you to.
- Infection caused by fungi in the esophagus (throat), which may cause difficulty swallowing.
Frequency unknown, but may also occur:
-Depression or aggression. It is more likely that these effects will occur in children.
- Blurred vision.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use Salmeterol/Fluticasona Cipla Inhaler after the expiration date that appears on the label and on the case after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
The cartridge contains pressurized liquid. Do not expose to temperatures above 50°C, protect from direct sunlight. Do not pierce or burn the cartridge even if it is empty.
As with most medications administered via inhalation in pressurized cartridges, the therapeutic effect may decrease if the cartridge cools down.
Medicines should not be thrown away through drains or in the trash. Dispose of the containers and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. In this way, you will help protect the environment.
Salmeterol/Fluticasona CompositionCipla
Each pressurized dose contains 25 micrograms of salmeterol (as xinafoate of salmeterol) and 125 micrograms of propionato of fluticasona.
This medication contains fluorinated greenhouse gases.
Each inhalator contains 12.5 g of HFC-134a (norflurano) corresponding to 0.018 tons of CO2equivalent (global warming potential PCG = 1430).
Product appearance and packaging contents
Marketing authorization holder and responsible manufacturer
Cipla Europe NV
De Keyserlei 60C, Bus-1301,
2018 Antwerp
Belgium
Local representative
Cipla Europe NV subsidiary in Spain,
C/ Guzmán el Bueno, 133 Edif Britannia-28003- Madrid
Last prospectus revision date:January 2025
The detailed information of this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.